Motor Neurons News and Research

RSS
Researchers identify FMRP protein as key player in RNA editing

Researchers identify FMRP protein as key player in RNA editing

FDA approves intraspinal injections in spinal cord stem cell ALS trial

FDA approves intraspinal injections in spinal cord stem cell ALS trial

Communication breakdown between nerves and muscles in SMA mouse model

Communication breakdown between nerves and muscles in SMA mouse model

Families help identify new gene for motor neuron disease

Families help identify new gene for motor neuron disease

Scientists discover new genetic mutation for amyotrophic lateral sclerosis

Scientists discover new genetic mutation for amyotrophic lateral sclerosis

Clinical trial to evaluate TAU's stem cell technology for ALS

Clinical trial to evaluate TAU's stem cell technology for ALS

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

Two ALS-associated genes work in tandem to support long-term survival of motor neurons

Two ALS-associated genes work in tandem to support long-term survival of motor neurons

Cellular pathology of Lou Gehrig’s disease discovered

Cellular pathology of Lou Gehrig’s disease discovered

Scientists identify common cause of all forms of amyotrophic lateral sclerosis

Scientists identify common cause of all forms of amyotrophic lateral sclerosis

New model for amyotrophic lateral sclerosis

New model for amyotrophic lateral sclerosis

SIGMAR1 gene mutation associated with development of juvenile ALS

SIGMAR1 gene mutation associated with development of juvenile ALS

Reduced levels of VAPB protein may play central role in causing ALS

Reduced levels of VAPB protein may play central role in causing ALS

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

New research on spinal muscular atrophy

New research on spinal muscular atrophy

Scientists direct embryonic, induced human stem cells to become astrocytes in lab dish

Scientists direct embryonic, induced human stem cells to become astrocytes in lab dish

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Being mildly overweight benefits ALS patients

Being mildly overweight benefits ALS patients

Repligen anticipates 30% increase in total revenues for 2011

Repligen anticipates 30% increase in total revenues for 2011

Blocking abnormal movement of mutated human FUS gene also blocks ALS process

Blocking abnormal movement of mutated human FUS gene also blocks ALS process